Polysaccharide-based Biomaterials: Delivery of Therapeutics and Biomedical Applications.
With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems.
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge :
Royal Society of Chemistry,
2022.
|
| Schlagworte: | |
| Online-Zugang: | DE-862 DE-863 |
| Zusammenfassung: | With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems. |
| Beschreibung: | Description based upon print version of record. 5.3 Application of Hyaluronic Acid in Gene Delivery Systems |
| Beschreibung: | 1 online resource (610 p.). |
| ISBN: | 183916624X 9781839166242 |
Internformat
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1349280040 | ||
| 003 | OCoLC | ||
| 005 | 20250103110447.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 221029s2022 xx o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |c EBLCP |d N$T |d OCLCF |d OCLCO |d OCLCL |d CLOUD |d OCLCO | ||
| 020 | |a 183916624X | ||
| 020 | |a 9781839166242 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1349280040 | ||
| 050 | 4 | |a QP702.P6 | |
| 082 | 7 | |a 572.566 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Polysaccharide-based Biomaterials |h [electronic resource] : |b Delivery of Therapeutics and Biomedical Applications. |
| 260 | |a Cambridge : |b Royal Society of Chemistry, |c 2022. | ||
| 300 | |a 1 online resource (610 p.). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Description based upon print version of record. | ||
| 505 | 0 | |a Intro -- Title -- Copyright -- Contents -- Chapter 1 Polysaccharide-based Biomaterials: Overview -- 1.1 Introduction -- 1.2 Cellulose -- 1.3 Chitosan -- 1.4 Modifications -- 1.5 Hyaluronic Acid -- 1.6 Dextran -- 1.7 Alginates -- 1.8 Pullulan -- 1.9 Chondroitin Sulfate -- 1.10 Conclusion -- References -- Chapter 2 Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine -- 2.1 Introduction -- 2.2 Alginate -- 2.2.1 Alginate: Chemical Structure and Characterization -- 2.2.2 Extraction of Alginate from Brown Seaweed Algae -- 2.3 Alginate-based Colloidal Systems | |
| 505 | 8 | |a 2.3.1 Alginate in Different Colloidal Systems -- 2.4 Alginate-based Carrier Applications in Delivery Systems and Biomedicine -- 2.4.1 Therapeutic Applications -- 2.4.2 Drug-controlled Release Systems -- 2.4.3 Biomedical Applications -- 2.5 Conclusions -- Acknowledgements -- References -- Chapter 3 Alginate-based Carriers for Transdermal Drug Delivery -- 3.1 Introduction -- 3.2 Alginate: Sources, Physicochemical, and Biological Properties -- 3.2.1 Sources of Alginates -- 3.2.2 Physicochemical Properties -- 3.2.3 Biological Properties of Alginates | |
| 505 | 8 | |a 3.3 Preparations of Different Alginate-based Transdermal Systems -- 3.3.1 Alginate Films -- 3.3.2 Alginate-based Microneedles for Transdermal Drug Delivery -- 3.3.3 Alginate-based Electroresponsive Transdermal Drug Delivery System -- 3.4 Drug Delivery Application of Alginate Based Transdermal Carriers -- 3.4.1 Delivery of Antidiabetic Agents -- 3.4.2 Delivery of Anticancer Agents -- 3.4.3 Delivery of Anti-inflammatory Agents -- 3.4.4 Delivery of Antibiotics -- 3.4.5 Delivery of Antihypertensive Agents -- 3.4.6 Delivery of Antifungal Agents -- 3.4.7 Delivery of Antimicrobial Agents | |
| 505 | 8 | |a 3.4.8 Delivery of Antioxidants -- 3.4.9 Delivery of Anti-alopecia Agents -- 3.4.10 Miscellaneous -- 3.5 Conclusion -- References -- Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges -- 4.1 Introduction -- 4.2 Chitosan-based Drug Delivery Nanocarriers -- 4.2.1 Nanoparticles -- 4.2.2 Nanogels -- 4.2.3 Nanomicelles -- 4.2.4 Physicochemical Characterization of Nanospheres, Nanocapsules, and Nanogels -- 4.2.5 Nanofibers -- 4.3 Summary and Future Perspectives -- Abbreviations -- Acknowledgements -- References -- Chapter 5 Hyaluronic Acid in Drug Delivery | |
| 505 | 8 | |a 5.1 Introduction -- 5.1.1 Properties -- 5.1.2 Synthesis and Degradation -- 5.2 Application of Hyaluronic Acid in Drug Delivery Systems -- 5.2.1 HA in Parenteral Delivery -- 5.2.2 HA in Pulmonary Delivery -- 5.2.3 HA in Ocular Delivery -- 5.2.4 HA in Nasal Delivery -- 5.2.5 HA in Oral Delivery -- 5.2.6 HA in Vaginal Delivery -- 5.2.7 HA in Topical Delivery -- 5.2.8 HA in Tissue and Regenerative Medicine -- 5.2.9 HA in Anti-cancer Drug Delivery Systems -- 5.2.10 HA in Protein and Peptide Delivery -- 5.2.11 HA in Targeted Drug Delivery Systems -- 5.2.12 HA in Self-assembling Systems | |
| 500 | |a 5.3 Application of Hyaluronic Acid in Gene Delivery Systems | ||
| 520 | |a With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems. | ||
| 650 | 0 | |a Polysaccharides. |0 http://id.loc.gov/authorities/subjects/sh85104728 | |
| 650 | 6 | |a Polysaccharides. | |
| 650 | 7 | |a Biomedical. |2 bisacsh | |
| 650 | 7 | |a Chemical & Biochemical. |2 bisacsh | |
| 650 | 7 | |a TECHNOLOGY & ENGINEERING. |2 bisacsh | |
| 650 | 7 | |a Materials Science. |2 bisacsh | |
| 650 | 7 | |a Polysaccharides |2 fast | |
| 655 | 0 | |a Electronic books. | |
| 700 | 1 | |a Jana, Sougata. |1 https://id.oclc.org/worldcat/entity/E39PCjycjwyqfV7CvCjhgCK883 |0 http://id.loc.gov/authorities/names/n2017188904 | |
| 700 | 1 | |a Jana, Subrata. |1 https://id.oclc.org/worldcat/entity/E39PCjqXrGR9bH3gWQ4ChDgG6q |0 http://id.loc.gov/authorities/names/n2017188903 | |
| 700 | 1 | |a Domb, A. J. |q (Abraham J.) |1 https://id.oclc.org/worldcat/entity/E39PBJj8WtY3CrtPFjCkF39Rrq |0 http://id.loc.gov/authorities/names/n93097405 | |
| 776 | 0 | 8 | |i Print version: |a Jana, Sougata |t Polysaccharide-based Biomaterials |d Cambridge : Royal Society of Chemistry,c2022 |z 9781839164989 |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3424169 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3424169 |3 Volltext |
| 938 | |a cloudLibrary |b CLDL |n 9781839166242 | ||
| 938 | |a cloudLibrary |b CLDL |n 9781839166235 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL7120845 | ||
| 938 | |a EBSCOhost |b EBSC |n 3424169 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1349280040 |
|---|---|
| _version_ | 1829095376123068416 |
| adam_text | |
| any_adam_object | |
| author2 | Jana, Sougata Jana, Subrata Domb, A. J. (Abraham J.) |
| author2_role | |
| author2_variant | s j sj s j sj a j d aj ajd |
| author_GND | http://id.loc.gov/authorities/names/n2017188904 http://id.loc.gov/authorities/names/n2017188903 http://id.loc.gov/authorities/names/n93097405 |
| author_facet | Jana, Sougata Jana, Subrata Domb, A. J. (Abraham J.) |
| author_sort | Jana, Sougata |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QP702 |
| callnumber-raw | QP702.P6 |
| callnumber-search | QP702.P6 |
| callnumber-sort | QP 3702 P6 |
| callnumber-subject | QP - Physiology |
| collection | ZDB-4-EBA |
| contents | Intro -- Title -- Copyright -- Contents -- Chapter 1 Polysaccharide-based Biomaterials: Overview -- 1.1 Introduction -- 1.2 Cellulose -- 1.3 Chitosan -- 1.4 Modifications -- 1.5 Hyaluronic Acid -- 1.6 Dextran -- 1.7 Alginates -- 1.8 Pullulan -- 1.9 Chondroitin Sulfate -- 1.10 Conclusion -- References -- Chapter 2 Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine -- 2.1 Introduction -- 2.2 Alginate -- 2.2.1 Alginate: Chemical Structure and Characterization -- 2.2.2 Extraction of Alginate from Brown Seaweed Algae -- 2.3 Alginate-based Colloidal Systems 2.3.1 Alginate in Different Colloidal Systems -- 2.4 Alginate-based Carrier Applications in Delivery Systems and Biomedicine -- 2.4.1 Therapeutic Applications -- 2.4.2 Drug-controlled Release Systems -- 2.4.3 Biomedical Applications -- 2.5 Conclusions -- Acknowledgements -- References -- Chapter 3 Alginate-based Carriers for Transdermal Drug Delivery -- 3.1 Introduction -- 3.2 Alginate: Sources, Physicochemical, and Biological Properties -- 3.2.1 Sources of Alginates -- 3.2.2 Physicochemical Properties -- 3.2.3 Biological Properties of Alginates 3.3 Preparations of Different Alginate-based Transdermal Systems -- 3.3.1 Alginate Films -- 3.3.2 Alginate-based Microneedles for Transdermal Drug Delivery -- 3.3.3 Alginate-based Electroresponsive Transdermal Drug Delivery System -- 3.4 Drug Delivery Application of Alginate Based Transdermal Carriers -- 3.4.1 Delivery of Antidiabetic Agents -- 3.4.2 Delivery of Anticancer Agents -- 3.4.3 Delivery of Anti-inflammatory Agents -- 3.4.4 Delivery of Antibiotics -- 3.4.5 Delivery of Antihypertensive Agents -- 3.4.6 Delivery of Antifungal Agents -- 3.4.7 Delivery of Antimicrobial Agents 3.4.8 Delivery of Antioxidants -- 3.4.9 Delivery of Anti-alopecia Agents -- 3.4.10 Miscellaneous -- 3.5 Conclusion -- References -- Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges -- 4.1 Introduction -- 4.2 Chitosan-based Drug Delivery Nanocarriers -- 4.2.1 Nanoparticles -- 4.2.2 Nanogels -- 4.2.3 Nanomicelles -- 4.2.4 Physicochemical Characterization of Nanospheres, Nanocapsules, and Nanogels -- 4.2.5 Nanofibers -- 4.3 Summary and Future Perspectives -- Abbreviations -- Acknowledgements -- References -- Chapter 5 Hyaluronic Acid in Drug Delivery 5.1 Introduction -- 5.1.1 Properties -- 5.1.2 Synthesis and Degradation -- 5.2 Application of Hyaluronic Acid in Drug Delivery Systems -- 5.2.1 HA in Parenteral Delivery -- 5.2.2 HA in Pulmonary Delivery -- 5.2.3 HA in Ocular Delivery -- 5.2.4 HA in Nasal Delivery -- 5.2.5 HA in Oral Delivery -- 5.2.6 HA in Vaginal Delivery -- 5.2.7 HA in Topical Delivery -- 5.2.8 HA in Tissue and Regenerative Medicine -- 5.2.9 HA in Anti-cancer Drug Delivery Systems -- 5.2.10 HA in Protein and Peptide Delivery -- 5.2.11 HA in Targeted Drug Delivery Systems -- 5.2.12 HA in Self-assembling Systems |
| ctrlnum | (OCoLC)1349280040 |
| dewey-full | 572.566 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 572 - Biochemistry |
| dewey-raw | 572.566 |
| dewey-search | 572.566 |
| dewey-sort | 3572.566 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05456cam a2200565Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-on1349280040</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20250103110447.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">221029s2022 xx o ||| 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="c">EBLCP</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">CLOUD</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">183916624X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781839166242</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1349280040</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP702.P6</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">572.566</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Polysaccharide-based Biomaterials</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Delivery of Therapeutics and Biomedical Applications.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Cambridge :</subfield><subfield code="b">Royal Society of Chemistry,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (610 p.).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Title -- Copyright -- Contents -- Chapter 1 Polysaccharide-based Biomaterials: Overview -- 1.1 Introduction -- 1.2 Cellulose -- 1.3 Chitosan -- 1.4 Modifications -- 1.5 Hyaluronic Acid -- 1.6 Dextran -- 1.7 Alginates -- 1.8 Pullulan -- 1.9 Chondroitin Sulfate -- 1.10 Conclusion -- References -- Chapter 2 Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine -- 2.1 Introduction -- 2.2 Alginate -- 2.2.1 Alginate: Chemical Structure and Characterization -- 2.2.2 Extraction of Alginate from Brown Seaweed Algae -- 2.3 Alginate-based Colloidal Systems</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.3.1 Alginate in Different Colloidal Systems -- 2.4 Alginate-based Carrier Applications in Delivery Systems and Biomedicine -- 2.4.1 Therapeutic Applications -- 2.4.2 Drug-controlled Release Systems -- 2.4.3 Biomedical Applications -- 2.5 Conclusions -- Acknowledgements -- References -- Chapter 3 Alginate-based Carriers for Transdermal Drug Delivery -- 3.1 Introduction -- 3.2 Alginate: Sources, Physicochemical, and Biological Properties -- 3.2.1 Sources of Alginates -- 3.2.2 Physicochemical Properties -- 3.2.3 Biological Properties of Alginates</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.3 Preparations of Different Alginate-based Transdermal Systems -- 3.3.1 Alginate Films -- 3.3.2 Alginate-based Microneedles for Transdermal Drug Delivery -- 3.3.3 Alginate-based Electroresponsive Transdermal Drug Delivery System -- 3.4 Drug Delivery Application of Alginate Based Transdermal Carriers -- 3.4.1 Delivery of Antidiabetic Agents -- 3.4.2 Delivery of Anticancer Agents -- 3.4.3 Delivery of Anti-inflammatory Agents -- 3.4.4 Delivery of Antibiotics -- 3.4.5 Delivery of Antihypertensive Agents -- 3.4.6 Delivery of Antifungal Agents -- 3.4.7 Delivery of Antimicrobial Agents</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.4.8 Delivery of Antioxidants -- 3.4.9 Delivery of Anti-alopecia Agents -- 3.4.10 Miscellaneous -- 3.5 Conclusion -- References -- Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges -- 4.1 Introduction -- 4.2 Chitosan-based Drug Delivery Nanocarriers -- 4.2.1 Nanoparticles -- 4.2.2 Nanogels -- 4.2.3 Nanomicelles -- 4.2.4 Physicochemical Characterization of Nanospheres, Nanocapsules, and Nanogels -- 4.2.5 Nanofibers -- 4.3 Summary and Future Perspectives -- Abbreviations -- Acknowledgements -- References -- Chapter 5 Hyaluronic Acid in Drug Delivery</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">5.1 Introduction -- 5.1.1 Properties -- 5.1.2 Synthesis and Degradation -- 5.2 Application of Hyaluronic Acid in Drug Delivery Systems -- 5.2.1 HA in Parenteral Delivery -- 5.2.2 HA in Pulmonary Delivery -- 5.2.3 HA in Ocular Delivery -- 5.2.4 HA in Nasal Delivery -- 5.2.5 HA in Oral Delivery -- 5.2.6 HA in Vaginal Delivery -- 5.2.7 HA in Topical Delivery -- 5.2.8 HA in Tissue and Regenerative Medicine -- 5.2.9 HA in Anti-cancer Drug Delivery Systems -- 5.2.10 HA in Protein and Peptide Delivery -- 5.2.11 HA in Targeted Drug Delivery Systems -- 5.2.12 HA in Self-assembling Systems</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">5.3 Application of Hyaluronic Acid in Gene Delivery Systems</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Polysaccharides.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85104728</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Polysaccharides.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomedical.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemical & Biochemical.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Materials Science.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Polysaccharides</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jana, Sougata.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjycjwyqfV7CvCjhgCK883</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2017188904</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jana, Subrata.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjqXrGR9bH3gWQ4ChDgG6q</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2017188903</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Domb, A. J.</subfield><subfield code="q">(Abraham J.)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJj8WtY3CrtPFjCkF39Rrq</subfield><subfield code="0">http://id.loc.gov/authorities/names/n93097405</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Jana, Sougata</subfield><subfield code="t">Polysaccharide-based Biomaterials</subfield><subfield code="d">Cambridge : Royal Society of Chemistry,c2022</subfield><subfield code="z">9781839164989</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3424169</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3424169</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">cloudLibrary</subfield><subfield code="b">CLDL</subfield><subfield code="n">9781839166242</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">cloudLibrary</subfield><subfield code="b">CLDL</subfield><subfield code="n">9781839166235</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL7120845</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3424169</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Electronic books. |
| genre_facet | Electronic books. |
| id | ZDB-4-EBA-on1349280040 |
| illustrated | Not Illustrated |
| indexdate | 2025-04-11T08:48:02Z |
| institution | BVB |
| isbn | 183916624X 9781839166242 |
| language | English |
| oclc_num | 1349280040 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource (610 p.). |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Royal Society of Chemistry, |
| record_format | marc |
| spelling | Polysaccharide-based Biomaterials [electronic resource] : Delivery of Therapeutics and Biomedical Applications. Cambridge : Royal Society of Chemistry, 2022. 1 online resource (610 p.). text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based upon print version of record. Intro -- Title -- Copyright -- Contents -- Chapter 1 Polysaccharide-based Biomaterials: Overview -- 1.1 Introduction -- 1.2 Cellulose -- 1.3 Chitosan -- 1.4 Modifications -- 1.5 Hyaluronic Acid -- 1.6 Dextran -- 1.7 Alginates -- 1.8 Pullulan -- 1.9 Chondroitin Sulfate -- 1.10 Conclusion -- References -- Chapter 2 Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine -- 2.1 Introduction -- 2.2 Alginate -- 2.2.1 Alginate: Chemical Structure and Characterization -- 2.2.2 Extraction of Alginate from Brown Seaweed Algae -- 2.3 Alginate-based Colloidal Systems 2.3.1 Alginate in Different Colloidal Systems -- 2.4 Alginate-based Carrier Applications in Delivery Systems and Biomedicine -- 2.4.1 Therapeutic Applications -- 2.4.2 Drug-controlled Release Systems -- 2.4.3 Biomedical Applications -- 2.5 Conclusions -- Acknowledgements -- References -- Chapter 3 Alginate-based Carriers for Transdermal Drug Delivery -- 3.1 Introduction -- 3.2 Alginate: Sources, Physicochemical, and Biological Properties -- 3.2.1 Sources of Alginates -- 3.2.2 Physicochemical Properties -- 3.2.3 Biological Properties of Alginates 3.3 Preparations of Different Alginate-based Transdermal Systems -- 3.3.1 Alginate Films -- 3.3.2 Alginate-based Microneedles for Transdermal Drug Delivery -- 3.3.3 Alginate-based Electroresponsive Transdermal Drug Delivery System -- 3.4 Drug Delivery Application of Alginate Based Transdermal Carriers -- 3.4.1 Delivery of Antidiabetic Agents -- 3.4.2 Delivery of Anticancer Agents -- 3.4.3 Delivery of Anti-inflammatory Agents -- 3.4.4 Delivery of Antibiotics -- 3.4.5 Delivery of Antihypertensive Agents -- 3.4.6 Delivery of Antifungal Agents -- 3.4.7 Delivery of Antimicrobial Agents 3.4.8 Delivery of Antioxidants -- 3.4.9 Delivery of Anti-alopecia Agents -- 3.4.10 Miscellaneous -- 3.5 Conclusion -- References -- Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges -- 4.1 Introduction -- 4.2 Chitosan-based Drug Delivery Nanocarriers -- 4.2.1 Nanoparticles -- 4.2.2 Nanogels -- 4.2.3 Nanomicelles -- 4.2.4 Physicochemical Characterization of Nanospheres, Nanocapsules, and Nanogels -- 4.2.5 Nanofibers -- 4.3 Summary and Future Perspectives -- Abbreviations -- Acknowledgements -- References -- Chapter 5 Hyaluronic Acid in Drug Delivery 5.1 Introduction -- 5.1.1 Properties -- 5.1.2 Synthesis and Degradation -- 5.2 Application of Hyaluronic Acid in Drug Delivery Systems -- 5.2.1 HA in Parenteral Delivery -- 5.2.2 HA in Pulmonary Delivery -- 5.2.3 HA in Ocular Delivery -- 5.2.4 HA in Nasal Delivery -- 5.2.5 HA in Oral Delivery -- 5.2.6 HA in Vaginal Delivery -- 5.2.7 HA in Topical Delivery -- 5.2.8 HA in Tissue and Regenerative Medicine -- 5.2.9 HA in Anti-cancer Drug Delivery Systems -- 5.2.10 HA in Protein and Peptide Delivery -- 5.2.11 HA in Targeted Drug Delivery Systems -- 5.2.12 HA in Self-assembling Systems 5.3 Application of Hyaluronic Acid in Gene Delivery Systems With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems. Polysaccharides. http://id.loc.gov/authorities/subjects/sh85104728 Polysaccharides. Biomedical. bisacsh Chemical & Biochemical. bisacsh TECHNOLOGY & ENGINEERING. bisacsh Materials Science. bisacsh Polysaccharides fast Electronic books. Jana, Sougata. https://id.oclc.org/worldcat/entity/E39PCjycjwyqfV7CvCjhgCK883 http://id.loc.gov/authorities/names/n2017188904 Jana, Subrata. https://id.oclc.org/worldcat/entity/E39PCjqXrGR9bH3gWQ4ChDgG6q http://id.loc.gov/authorities/names/n2017188903 Domb, A. J. (Abraham J.) https://id.oclc.org/worldcat/entity/E39PBJj8WtY3CrtPFjCkF39Rrq http://id.loc.gov/authorities/names/n93097405 Print version: Jana, Sougata Polysaccharide-based Biomaterials Cambridge : Royal Society of Chemistry,c2022 9781839164989 |
| spellingShingle | Polysaccharide-based Biomaterials Delivery of Therapeutics and Biomedical Applications. Intro -- Title -- Copyright -- Contents -- Chapter 1 Polysaccharide-based Biomaterials: Overview -- 1.1 Introduction -- 1.2 Cellulose -- 1.3 Chitosan -- 1.4 Modifications -- 1.5 Hyaluronic Acid -- 1.6 Dextran -- 1.7 Alginates -- 1.8 Pullulan -- 1.9 Chondroitin Sulfate -- 1.10 Conclusion -- References -- Chapter 2 Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine -- 2.1 Introduction -- 2.2 Alginate -- 2.2.1 Alginate: Chemical Structure and Characterization -- 2.2.2 Extraction of Alginate from Brown Seaweed Algae -- 2.3 Alginate-based Colloidal Systems 2.3.1 Alginate in Different Colloidal Systems -- 2.4 Alginate-based Carrier Applications in Delivery Systems and Biomedicine -- 2.4.1 Therapeutic Applications -- 2.4.2 Drug-controlled Release Systems -- 2.4.3 Biomedical Applications -- 2.5 Conclusions -- Acknowledgements -- References -- Chapter 3 Alginate-based Carriers for Transdermal Drug Delivery -- 3.1 Introduction -- 3.2 Alginate: Sources, Physicochemical, and Biological Properties -- 3.2.1 Sources of Alginates -- 3.2.2 Physicochemical Properties -- 3.2.3 Biological Properties of Alginates 3.3 Preparations of Different Alginate-based Transdermal Systems -- 3.3.1 Alginate Films -- 3.3.2 Alginate-based Microneedles for Transdermal Drug Delivery -- 3.3.3 Alginate-based Electroresponsive Transdermal Drug Delivery System -- 3.4 Drug Delivery Application of Alginate Based Transdermal Carriers -- 3.4.1 Delivery of Antidiabetic Agents -- 3.4.2 Delivery of Anticancer Agents -- 3.4.3 Delivery of Anti-inflammatory Agents -- 3.4.4 Delivery of Antibiotics -- 3.4.5 Delivery of Antihypertensive Agents -- 3.4.6 Delivery of Antifungal Agents -- 3.4.7 Delivery of Antimicrobial Agents 3.4.8 Delivery of Antioxidants -- 3.4.9 Delivery of Anti-alopecia Agents -- 3.4.10 Miscellaneous -- 3.5 Conclusion -- References -- Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges -- 4.1 Introduction -- 4.2 Chitosan-based Drug Delivery Nanocarriers -- 4.2.1 Nanoparticles -- 4.2.2 Nanogels -- 4.2.3 Nanomicelles -- 4.2.4 Physicochemical Characterization of Nanospheres, Nanocapsules, and Nanogels -- 4.2.5 Nanofibers -- 4.3 Summary and Future Perspectives -- Abbreviations -- Acknowledgements -- References -- Chapter 5 Hyaluronic Acid in Drug Delivery 5.1 Introduction -- 5.1.1 Properties -- 5.1.2 Synthesis and Degradation -- 5.2 Application of Hyaluronic Acid in Drug Delivery Systems -- 5.2.1 HA in Parenteral Delivery -- 5.2.2 HA in Pulmonary Delivery -- 5.2.3 HA in Ocular Delivery -- 5.2.4 HA in Nasal Delivery -- 5.2.5 HA in Oral Delivery -- 5.2.6 HA in Vaginal Delivery -- 5.2.7 HA in Topical Delivery -- 5.2.8 HA in Tissue and Regenerative Medicine -- 5.2.9 HA in Anti-cancer Drug Delivery Systems -- 5.2.10 HA in Protein and Peptide Delivery -- 5.2.11 HA in Targeted Drug Delivery Systems -- 5.2.12 HA in Self-assembling Systems Polysaccharides. http://id.loc.gov/authorities/subjects/sh85104728 Polysaccharides. Biomedical. bisacsh Chemical & Biochemical. bisacsh TECHNOLOGY & ENGINEERING. bisacsh Materials Science. bisacsh Polysaccharides fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85104728 |
| title | Polysaccharide-based Biomaterials Delivery of Therapeutics and Biomedical Applications. |
| title_auth | Polysaccharide-based Biomaterials Delivery of Therapeutics and Biomedical Applications. |
| title_exact_search | Polysaccharide-based Biomaterials Delivery of Therapeutics and Biomedical Applications. |
| title_full | Polysaccharide-based Biomaterials [electronic resource] : Delivery of Therapeutics and Biomedical Applications. |
| title_fullStr | Polysaccharide-based Biomaterials [electronic resource] : Delivery of Therapeutics and Biomedical Applications. |
| title_full_unstemmed | Polysaccharide-based Biomaterials [electronic resource] : Delivery of Therapeutics and Biomedical Applications. |
| title_short | Polysaccharide-based Biomaterials |
| title_sort | polysaccharide based biomaterials delivery of therapeutics and biomedical applications |
| title_sub | Delivery of Therapeutics and Biomedical Applications. |
| topic | Polysaccharides. http://id.loc.gov/authorities/subjects/sh85104728 Polysaccharides. Biomedical. bisacsh Chemical & Biochemical. bisacsh TECHNOLOGY & ENGINEERING. bisacsh Materials Science. bisacsh Polysaccharides fast |
| topic_facet | Polysaccharides. Biomedical. Chemical & Biochemical. TECHNOLOGY & ENGINEERING. Materials Science. Polysaccharides Electronic books. |
| work_keys_str_mv | AT janasougata polysaccharidebasedbiomaterialsdeliveryoftherapeuticsandbiomedicalapplications AT janasubrata polysaccharidebasedbiomaterialsdeliveryoftherapeuticsandbiomedicalapplications AT dombaj polysaccharidebasedbiomaterialsdeliveryoftherapeuticsandbiomedicalapplications |